- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
While Big Pharma has launched an all out campaign to oust Robert F. Kennedy, Jr. and his MAHA supporters from government, the global processed food industry has taken a much more accommodating tack:
https://www.politico.com/news/2025/09/13/maha-kennedy-trump-food-industry-washington-00561830
Publicly, this industry has been mostly quiet about MAHA. Privately, they’re panicking.
Major food companies are struggling to maintain decades-old alliances as the Make America Healthy Again movement tightens its grip on the GOP.
By Marcia Brown - September 13, 2025Some of the world’s biggest food companies are confronting a strange reality in Washington: They’re no longer getting their way.
After decades of seeing glad-handing on Capitol Hill and positive relations with the White House pay off in policy wins, food industry lobbyists are finding fewer receptive audiences and even struggling to get key meetings as consumer trends and a triumphant political movement fracture old alliances.
“Most of the food industry is like the stunned fish you get when you stick a cattle prod in a fish pond,” said one long-time food industry lobbyist granted anonymity to speak candidly.
The White House’s plan to improve children’s health, released Tuesday, is the clearest signal yet that Robert F. Kennedy Jr.’s Make America Healthy Again agenda is scrambling the equation for how K street wields its influence, leaving the food industry divided and confused.
While farm groups were able to persuade the White House to dial back its criticism of pesticides, companies that manufacture processed foods are instead seeing the Health and Human Services secretary pushing front-of-pack nutrition labeling, tighter regulations of ultra-processed foods and new limits on additives — all changes that could have significant financial implications for their trillion-dollar industry.
“These are not surprises,” said a second industry representative granted anonymity to speak candidly. “But that doesn’t mean that … this is not still a fundamental change in some things for the industry that we’re going to have to be prepared to deal with.
This account, which is based on nine interviews with representatives across the food and consumer packaged goods industry, paints a picture of a food sector at war with itself over how to respond to White House attacks — or whether to respond at all.
Tuesday’s MAHA strategy report comes as the industry is facing sweeping changes: Weight-loss drugs are shrinking serving size, states are banning ultra-processed foods from school lunches and tariffs are decimating profit margins.
Though it didn’t meaningfully change the administration’s position on food additives or labeling, some in the industry thought the MAHA strategy report represented a shift. For one, some in the industry were invited to share feedback before its publication. At the report’s launch, White House Domestic Policy Council Director Vince Haley even namechecked “recommendations from industry.” But most lobbyists are still skeptical that it’s anything more than “a bright spot,” as a third person described it.
It wouldn’t be the first time Kennedy offered an olive branch to industry without much changing his position.
He asserted during his Senate confirmation hearing in January that regulators were allowing top food brands like McDonald’s to “mass poison American children.” But two months later, he was doing a television hit at Steak ‘n Shake praising the company’s decision “RFK’ing the french fries” — swapping vegetable oil for beef tallow.
The apparent contradiction is leaving the food industry floundering. A fourth industry lobbyist said it was part of the White House’s strategy to “keep folks on their heels.”
While some parts of the food industry have won praise from administration officials for making voluntary commitments that align with White House priorities, others are struggling with their approach. Several groups and companies have shied away from publicly criticizing the administration out of fear they could become the focus of a presidential social media post, which could color consumer sentiment against their products.
In April, the American Beverage Association — a trade group representing Coca-Cola and PepsiCo among others — criticized the Trump administration for supporting a ban on food stamp recipients purchasing soda with their benefits.
Calley Means, who serves under Kennedy as a special government employee at the Department of Health and Human Services, immediately shot back: “You have lobbied millions to ensure taxpayer money funds soda for poor kids,” he posted on X.
Agriculture Secretary Brooke Rollins piled on. “It’s disappointing that the American Beverage Association’s leadership dragged its entire membership ... into direct conflict with this Administration’s priorities for American health, well-being, and taxpayer protection.”
The episode left an impression.
“There’s a keen hesitance to say anything and call a spade a spade,” said a fifth industry representative. “That’s a very different universe. Since when do big companies refrain?”
While many member companies want their trade associations to push back, the groups have largely shied away from public criticism, opting instead for voluntary commitment pledges, such as removing food dyes.
A sixth industry representative noted the surprising absence of an industry coalescing around a single mission to counter the administration.
“The rise of this sort of anti-institution sentiment and antigovernment, anti-everything has had an impact on the food industry’s ability to exert their influence,” the person added.
At the MAHA Commission’s news conference Tuesday, Rollins lauded the dairy industry for committing to cut artificial dyes from its products “even though it might hurt” companies’ bottom lines. The Trump administration is even tracking company and trade group commitments to eliminate such additives on the FDA’s website.
Groups like the Consumer Brands Association, which represents food companies like General Mills and Nestlé, are announcing voluntary programs to encourage members to eliminate artificial food dyes — over the objections of some companies. Still, other groups like the American Beverage Association are attempting to ratchet up consumer transparency by listing ingredients their members use that weren’t previously disclosed, allowed by what critics see as a loophole in the Food and Drug Administration’s regulations.
Despite these efforts, Kennedy continues to disparage their products, repeatedly saying that some of America’s most popular food items are making people sick. That rhetoric — even if it’s yet to be accompanied by serious regulatory change — has become increasingly difficult for the industry to counter. Many food lobbyists privately express similar concerns to Kennedy about chronic disease though they argue that the MAHA Commission’s proposals will do little to solve it.
And the industry recognizes that going after sugary drinks and processed food is popular across the political spectrum, making it an easy target despite company pledges to appease Kennedy on food dyes, seed oils and more.
Said a seventh lobbyist: “Is this a distraction because vaccines are so politically polarizing and there’s wins to be had here, so they’re going to come back for more?”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















